Endoxifen hydrochloride

CAS No. 1197194-41-4

Endoxifen hydrochloride ( —— )

Catalog No. M10698 CAS No. 1197194-41-4

A metabolite of tamoxifen, orally active non-steroidal selective estrogen receptor modulator (SERM) for the treatment of estrogen receptor-positive breast cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 Get Quote
10MG 59 Get Quote
25MG 120 Get Quote
50MG 209 Get Quote
100MG 337 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Endoxifen hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A metabolite of tamoxifen, orally active non-steroidal selective estrogen receptor modulator (SERM) for the treatment of estrogen receptor-positive breast cancer.
  • Description
    A metabolite of tamoxifen, orally active non-steroidal selective estrogen receptor modulator (SERM) for the treatment of estrogen receptor-positive breast cancer.Breast Cancer Phase 1 Clinical
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    Estrogen Receptor/ERR
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    1197194-41-4
  • Formula Weight
    409.95
  • Molecular Formula
    C25H28ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 35 mg/mL
  • SMILES
    CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3.Cl
  • Chemical Name
    Phenol, 4-[1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-, hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Brauch H, et al. Clin Chem. 2009 Oct;55(10):1770-82.
2. Markopoulos C, et al. World J Clin Oncol. 2014 Aug 10;5(3):374-81.
3. Mugundu GM, et al. Drug Metab Dispos. 2012 Feb;40(2):389-96.
molnova catalog
related products
  • Melibiose

    Melibiose is a reducing disaccharide formed by an alpha-1, 6 linkage between galactose and glucose (D-Gal-α(1→6)-D-Glc).

  • OP-1074

    OP-1074 (OP1074) is a potent, selective ER degrader (SERD), shows specific antiestrogenic activity for both ERα and Erβ.

  • Fulvestrant

    Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.